The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Outcomes of Kidney Transplantation in HIV-Infected Recipients
Open accessAbstract
BACKGROUND: The outcomes of kidney transplantation and immunosuppression in people infected with human immunodeficiency virus (HIV) are incompletely understood. METHODS: We undertook a prospective, nonrandomized trial of kidney transplantation in HIV-infected candidates who had CD4+ T-cell counts of at least 200 per cubic millimeter and undetectable plasma HIV type 1 (HIV-1) RNA levels while being treated with a stable antiretroviral regimen. Post-transplantation management was provided in accordance with study protocols that defined prophylaxis against opportunistic infection, indications for biopsy, and acceptable approaches to immunosuppression, management of rejection, and antiretroviral therapy. RESULTS: Between November 2003 and June 2009, a total of 150 patients underwent kidney transplantation; survivors were followed for a median period of 1.7 years. Patient survival rates (±SD) at 1 year and 3 years were 94.6±2.0% and 88.2±3.8%, respectively, and the corresponding mean graft-survival rates were 90.4% and 73.7%. In general, these rates fall somewhere between those reported in the national database for older kidney-transplant recipients (≥65 years) and those reported for all kidney-transplant recipients. A multivariate proportional-hazards analysis showed that the risk of graft loss was increased among patients treated for rejection (hazard ratio, 2.8; 95% confidence interval [CI], 1.2 to 6.6; P=0.02) and those receiving antithymocyte globulin induction therapy (hazard ratio, 2.5; 95% CI, 1.1 to 5.6; P=0.03); living-donor transplants were protective (hazard ratio, 0.2; 95% CI, 0.04 to 0.8; P=0.02). A higher-than-expected rejection rate was observed, with 1-year and 3-year estimates of 31% (95% CI, 24 to 40) and 41% (95% CI, 32 to 52), respectively. HIV infection remained well controlled, with stable CD4+ T-cell counts and few HIV-associated complications. CONCLUSIONS: In this cohort of carefully selected HIV-infected patients, both patient- and graft-survival rates were high at 1 and 3 years, with no increases in complications associated with HIV infection. The unexpectedly high rejection rates are of serious concern and indicate the need for better immunotherapy. (Funded by the National Institute of Allergy and Infectious Diseases; ClinicalTrials.gov number, NCT00074386.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Temporal Trends in Rates of Patient Harm Resulting from Medical Care
Landrigan, C. P., Parry, G. J., Bones, C. B., Hackbarth, A. D., Goldmann, D. A., & Sharek, P. J. (2010) · New England Journal of Medicine · doi:10.1056/nejmsa1004404 · Cited by 1,144
Sirolimus for Kaposi's Sarcoma in Renal-Transplant Recipients
Stallone, G., Schena, A., Infante, B., Di Paolo, S., Loverre, A., Maggio, G., Ranieri, E., Gesualdo, L., Schena, F. P., & Grandaliano, G. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042831 · Cited by 990
Heterologous immunity provides a potent barrier to transplantation tolerance
Adams, A. B., Williams, M. A., Jones, T. R., Shirasugi, N., Durham, M. M., Kaech, S. M., Wherry, E. J., Onami, T., Lanier, J. G., Kokko, K. E., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17477 · Cited by 617
Heterologous immunity provides a potent barrier to transplantation tolerance
Adams, A. B., Williams, M. A., Jones, T. R., Shirasugi, N., Durham, M. M., Kaech, S. M., Wherry, E. J., Onami, T., Lanier, J. G., Kokko, K. E., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200317477 · Cited by 616
Cyclosporin A Suppresses Replication of Hepatitis C Virus Genome in Cultured Hepatocytes
Watashi, K., Hijikata, M., Hosaka, M., Yamaji, M., & Shimotohno, K. (2003) · Hepatology · doi:10.1053/jhep.2003.50449 · Cited by 510
Homeostatic proliferation is a barrier to transplantation tolerance
Wu, Z., Bensinger, S. J., Zhang, J., Chen, C., Yuan, X., Huang, X., Markmann, J. F., Kassaee, A., Rosengard, B. R., Hancock, W. W., et al. (2004) · Nature Medicine · doi:10.1038/nm965 · Cited by 401
HIV-Infected Liver and Kidney Transplant Recipients: 1- and 3-Year Outcomes
Roland, M. E., Barin, B., Carlson, L., Frassetto, L. A., Terrault, N. A., Hirose, R., Freise, C. E., Benet, L. Z., Ascher, N. L., Roberts, J. P., et al. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2007.02061.x · Cited by 247
Self-citationMemory of mice and men: CD8+ T‐cell cross‐reactivity and heterologous immunity
Selin, L. K., Brehm, M. A., Naumov, Y. N., Cornberg, M., Kim, S., Clute, S. C., & Welsh, R. M. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00394.x · Cited by 177
Recent Progress in HIV-Associated Nephropathy
Wyatt, C. M., Meliambro, K., & Klotman, P. E. (2012) · Annual Review of Medicine · doi:10.1146/annurev-med-041610-134224 · Cited by 173
Frassetto, L. A., Browne, M., Cheng, A., Wolfe, A. R., Roland, M. E., Stock, P. G., Carlson, L., & Benet, L. Z. (2007) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2007.02007.x · Cited by 165
Self-citation
Cited by
Long-Term Survival after Kidney Transplantation
Hariharan, S., Israni, A. K., & Danovitch, G. (2021) · New England Journal of Medicine · doi:10.1056/nejmra2014530 · Cited by 664
Lucas, G. M., Ross, M. J., Stock, P. G., Shlipak, M. G., Wyatt, C. M., Gupta, S. K., Atta, M. G., Wools-Kaloustian, K. K., Pham, P. A., Bruggeman, L. A., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu617 · Cited by 310
Self-citationRealizing HOPE: The ethics of organ transplantation from HIV-positive donors
Durand, C. M., Segev, D., & Sugarman, J. (2016) · Annals of Internal Medicine · doi:10.7326/m16-0560 · Cited by 63
The feasibility of lung transplantation in HIV-seropositive patients
Kern, R. M., Seethamraju, H., Blanc, P. D., Sinha, N., Loebe, M., Golden, J., Kukreja, J., Scheinin, S., Hays, S., Kleinhenz, M. E., et al. (2014) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201402-083oc · Cited by 58
Heart or lung transplant outcomes in HIV-infected recipients
Koval, C. E., Farr, M., Krisl, J., Haidar, G., Pereira, M. R., Shrestha, N., Malinis, M. F., Mueller, N. J., Hannan, M. M., Grossi, P., et al. (2019) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2019.09.011 · Cited by 55
Metadata
- Authors
- Stock, P. G., Barin, B., Murphy, B., Hanto, D., Diego, J. M., Light, J., Davis, C., Blumberg, E., Simon, D., Subramanian, A., Millis, J. M., Lyon, G. M., Brayman, K., Slakey, D., Shapiro, R., Melancon, J., Jacobson, J. M., Stosor, V., Olson, J. L., Stablein, D. M., & Roland, M. E.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2010-11-18
- Volume
- 363
- Issue
- 21
- Pages
- 2004-2014
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2049747948
- Cited by
- 531
- References
- 21
- FWCI
- 25.07
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Outcomes of Kidney Transplantation in HIV-Infected Recipients. https://app.cochat.ai/papers/10.1056/nejmoa1001197
- The paper
- Stock, P. G., Barin, B., Murphy, B., Hanto, D., Diego, J. M., Light, J., Davis, C., Blumberg, E., Simon, D., Subramanian, A., Millis, J. M., Lyon, G. M., Brayman, K., Slakey, D., Shapiro, R., Melancon, J., Jacobson, J. M., Stosor, V., Olson, J. L., . . . Roland, M. E. (2010). Outcomes of Kidney Transplantation in HIV-Infected Recipients. New England Journal of Medicine. https://doi.org/10.1056/nejmoa1001197
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.